文献速递前列腺癌

根治性前列腺切除术后阿片类药物使用:瑞典全国人群研究

Opioid Use after Radical Prostatectomy: Nationwide, Population Based Study in Sweden.
PubMed 文献 · J Urol · 2019-07-17

该研究基于瑞典国家前列腺癌登记库和处方药登记库,纳入25,703例接受根治性前列腺切除术的男性,评估术后慢性阿片类药物使用风险。结果显示64%患者在围手术期填写过阿片类药物处方,但仅不到1%成为慢性使用者,低于北美既往报道。

要点

  • 瑞典根治性前列腺切除术后慢性阿片类药物使用率低于1%。
  • 64%患者围手术期填写过阿片类药物处方,术后2个月后降至2.2%。
  • 慢性晚期使用者中57%为既往使用者,43%为新发慢性使用者。

核心结论

  • 瑞典根治性前列腺切除术后慢性阿片类药物使用率低于1%,低于北美既往研究报道。

研究设计与样本

  • 全国性 population based 研究,纳入瑞典国家前列腺癌登记库中25,703例接受根治性前列腺切除术的男性,并与处方药登记库链接。

主要发现

  • 总体16,368例(64%)患者在术前13个月至术后期间填写过阿片类药物处方。
  • 强阿片类药物使用随时间增加,弱阿片类药物使用减少。
  • 基线期阿片类药物处方比例为1.9%,手术前后升至59%,术后第2个月急剧下降,此后维持在2.2%,略高于基线。
  • 慢性晚期使用者中57%为既往使用者,43%为新发慢性使用者。
  • 更高的癌症风险等级、更严重的合并症、未婚状态和低教育水平与新发慢性阿片类药物使用风险相关。

临床怎么用

  • 根治性前列腺切除术后慢性阿片类药物使用风险较低,但仍需关注高危患者(高癌症风险、合并症多、未婚、低教育水平)的长期阿片类药物使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: North American studies have revealed that about 3% to 7% of opioid naïve surgical patients transition to chronic opioid use after a single prescription. We examined the risk of chronic opioid use following radical prostatectomy using nationwide Swedish data. MATERIALS AND METHODS: A total of 25,703 men in the National Prostate Cancer Register of Sweden who underwent radical prostatectomy were linked to the Prescribed Drug Register. Opioid use was assessed at 3 times, including baseline (13 months to 1 month preoperatively), perioperatively (1 month before and after) and postoperatively (1 to 12 months). Multivariable logistic regression was done to identify predictors of new late use (1 or more opioid prescriptions in 3 consecutive months more than 2 months after surgery). RESULTS: Overall 16,368 men (64%) filled an opioid prescription during the 13 months before or after surgery. The use of strong opioids increased with time and the use of weak opioids decreased. Of the men 1.9% had opioid prescriptions during the baseline period, followed by a spike to 59% around the time surgery, which sharply decreased in month 2 postoperatively. However, thereafter the proportion of men with opioid prescriptions remained slightly higher at 2.2% compared to the baseline before radical prostatectomy. Of chronic late users 57% were previous users and 43% were new chronic users. Higher cancer risk category, greater comorbidity, unmarried status and low educational level were associated with the risk of new chronic opioid use. CONCLUSIONS: Slightly more than half of male Swedish patients filled an opioid prescription after radical prostatectomy and less than 1% became chronic opioid users. These rates are lower than in previous studies of postoperative opioid use from North America.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Loeb S, Cazzaniga W, Robinson D, et al. Opioid Use after Radical Prostatectomy: Nationwide, Population Based Study in Sweden. J Urol. 2019. PMID: 31584849. doi:10.1097/JU.0000000000000451

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。